Further study of mechanoactivation of VEGFR-2 and the subsequent signaling cascades would provide a deeper understanding of VEGFR-2 mechanoregulation that could potentially identify novel targets for anti-angiogenic therapies in cancer treatments. This evidence concerns the gene KDR and cancer.